0001209191-17-031672.txt : 20170511
0001209191-17-031672.hdr.sgml : 20170511
20170511200353
ACCESSION NUMBER: 0001209191-17-031672
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170509
FILED AS OF DATE: 20170511
DATE AS OF CHANGE: 20170511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1217
BUSINESS ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-697-3939
MAIL ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zanganeh Maky
CENTRAL INDEX KEY: 0001507650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 17836040
MAIL ADDRESS:
STREET 1: C/O PHARMACYCLICS, INC.
STREET 2: 995 EAST ARQUES AVENUE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-09
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001507650
Zanganeh Maky
849 MITTEN ROAD, SUITE 104
BURLINGAME
CA
94010
1
0
0
0
Common Stock
2017-05-11
4
P
0
15000
20.836
A
278935
D
Common Stock
2017-05-09
4
P
0
33760
20.157
A
80474
I
Dependent Minor
Common Stock
2017-05-10
4
P
0
5000
21.709
A
85474
I
Dependent Minor
This is the weighted average purchase price of the shares, which ranged from $20.66 to $20.945 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $19.885 to $20.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $20.99 to $21.921 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Brian Dow, as Attorney-in-Fact for Maky Zanganeh
2017-05-11